Baxter Logo (Image 01)
Magnesium Sulfate Injection, Solution
Product Images NDC 0338-1719
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Magnesium Sulfate (NDC 0338-1719). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Magnesium Sulfate In Water Representative Container Label 0338-1708-40 (Image 02)
Label for Magnesium Sulfate Injection, Solution, 2 g/50 mL (40 mg/mL) by Baxter Healthcare Corporation. The sterile, nonpyrogenic solution contains 2 g Magnesium Sulfate Heptahydrate per 50 mL in water for injection. The label includes pH, osmolality, storage, and usage instructions, and warnings about container materials and use conditions.*
Magnesium Sulfate In Water Representative Container Label 0338-1715-40 (Image 03)
Label for Magnesium Sulfate Injection, Solution 4 g/100 mL by Baxter Healthcare Corporation. The sterile, nonpyrogenic intravenous solution contains Magnesium Sulfate Heptahydrate equivalent to 4 g total magnesium per 100 mL. The single-dose container is for infusion and includes storage and usage instructions, with labeling indicating it is prescription only, made in Ireland.*
Magnesium Sulfate In Water Representative Container Label 0338-1719-40 (Image 04)
Label for Magnesium Sulfate Injection, Solution, 4 g/50 mL (80 mg/mL) by Baxter Healthcare Corporation. The label specifies a sterile, nonpyrogenic solution containing Magnesium Sulfate Heptahydrate in water for injection, with pH 4.5. It is intended for intravenous infusion from a single-dose container. The label includes storage instructions, usage precautions, a barcode, and manufacturing details showing it is made in Ireland.*
Image 05
Magnesium Sulfate injection, solution for intravenous use, 2 g/50 mL (40 mg/mL) strength. The label states 2 g total per container and specifies the active ingredient as Magnesium Sulfate Heptahydrate 2 g (equivalent to 16.25 mEq magnesium) per 50 mL of sterile, nonpyrogenic solution. It includes handling instructions, storage temperature, a note on pH 4.5 (range 3.5 to 6.5), and warnings such as using a central route and discarding unused portions. The labeler is Baxter Healthcare Corporation, with manufacturing in Ireland.*
Image 06
Label for Magnesium Sulfate in Water for Injection, 4 g/100 mL (40 mg/mL) intravenous injection solution. The label includes usage instructions, pH range (4.5, 3.5 to 6.5), and safety warnings. It is a single-dose container with 100 mL volume, manufactured by Baxter Healthcare Corporation, made in Ireland. The barcode, lot number, and storage conditions are also shown.*
Image 07
Label of Magnesium Sulfate Injection, Solution 4 g/50 mL (80 mg/mL) for intravenous use by Baxter Healthcare Corporation. The sterile, nonpyrogenic solution contains magnesium sulfate heptahydrate equivalent to 4 g total per 50 mL. The label includes dosage form, pH 4.5, administration instructions, storage conditions, and manufacturer information, with barcode and NDC 0338-1719-40.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
